Soligenix
SNGX
#10276
Rank
A$18.1 M
Marketcap
A$1.79
Share price
-4.58%
Change (1 day)
-52.67%
Change (1 year)

Earnings for Soligenix (SNGX)

Earnings in 2025 (TTM): -A$19.38 Million

According to Soligenix's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -A$13.43 Million a decrease over its 2023 earnings that were of -A$10.92 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Soligenix from 1998 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$19.38 Million44.37%
2024 -A$13.43 Million22.96%
2023 -A$10.92 Million-45.74%
2022 -A$20.12 Million11.88%
2021 -A$17.99 Million-32.37%
2020 -A$26.59 Million83.18%
2019 -A$14.52 Million11.57%
2018 -A$13.01 Million19.29%
2017 -A$10.91 Million33%
2016 -A$8.2 Million-19.7%
2015 -A$10.22 Million5.16%
2014 -A$9.71 Million
2010 -A$10.96 Million26.12%
2009 -A$8.69 Million75.1%
2008 -A$4.97 Million-45.38%
2007 -A$9.09 Million-22.84%
2006 -A$11.78 Million66.15%
2005 -A$7.09 Million-16.65%
2004 -A$8.51 Million13.28%
2003 -A$7.51 Million-11.88%
2002 -A$8.52 Million-59.44%
2001 -A$21.01 Million378.18%
2000 -A$4.4 Million-38.53%
1999 -A$7.15 Million-18.43%
1998 -A$8.76 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$46.52 B-262,014.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$17.01 B-95,920.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$13.06 B-73,673.72%๐Ÿ‡ซ๐Ÿ‡ท France
Onconova Therapeutics
ONTX
-A$26.08 Million 46.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-A$59.98 Million 237.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$2.54 B-14,426.25%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Cleveland BioLabs
CBLI
-A$3.96 Million-77.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A$0.23 B-1,436.42%๐Ÿ‡บ๐Ÿ‡ธ USA